CIK: 1397266 - Address: C/O Neumora Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown, MA 02472
38 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret1160330-12233
S%wins5040407567045

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/18/24 18:25
10/17/24
NMRANeumora Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFust Matthew KMADS.dm-37117.030-22-5220D
3/22/24 16:31
3/20/24
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-2,64844.140-60-7619D
3/11/24 12:54
3/7/24
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-62050.880-12-4515D
7/15/22 16:30
7/13/22
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-11920.960-6-3113D
11/5/21 16:28
11/4/21
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFust Matthew KCADS-26019.500-13-3032D
11/3/21 16:55
11/1/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-22825.500-9-4213D
9/9/21 17:00
9/8/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-15425.500-6-3313D
7/27/21 20:00
7/26/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-9819.590-5-2913D
7/20/21 17:00
7/19/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-9819.500-5-2913D
7/13/21 17:00
7/12/21
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-10420.710-5-2913D
7/8/20 12:30
7/6/20
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-55690.000-6-3114D
7/6/20 14:21
7/1/20
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-42585.000-5-2714D
5/19/20 19:13
5/18/20
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-14175.000-2-1511D
4/24/20 13:00
4/22/20
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-12265.000-2-1313D
12/26/19 16:13
12/24/19
DERMDermira, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-4515.000-3-375D
12/18/19 18:32
12/16/19
CRNXCrinetics Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS.d-7922.500-4-2213D
12/13/19 17:13
12/12/19
DERMDermira, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-3612.000-3-278D
9/16/19 16:09
9/12/19
DERMDermira, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-538.770-6-3511D
2/8/19 17:41
2/6/19
MGNXMacrogenics IncDEHealthDrugPharmaceutical PreparationsFust Matthew KMDDS.d-20329.380-7-931D
10/19/18 16:24
10/19/18
DERMDermira, Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-5513.750-4-2214D
5/30/18 19:26
5/30/18
RAREUltragenyx Pharmaceutical Inc.DEHealthDrugPharmaceutical PreparationsFust Matthew KCADS-45572.000-6-429D
5/16/18 20:40
5/14/18
ATRAAtara Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagFust Matthew KCADS.d-53543.570-12-3820D
8/12/13 19:11
8/8/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS-319128.210-2-640D
7/29/13 19:45
7/26/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS-789130.500-6-1243D
7/5/13 16:03
7/2/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS-206132.800-2-349D
5/15/13 18:51
5/13/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS.d-1,00998.220-10-1750D
4/16/13 16:23
4/15/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS-12895.150-1-350D
4/3/13 19:51
4/1/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS-33386.140-4-752D
3/4/13 18:39
2/28/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS.d-1,15777.120-15-2545D
1/11/13 20:32
1/10/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOEVP,CFOS.d-86684.870-10-1750D
8/8/12 21:48
8/6/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS.d-1,57871.710-22-2663D
7/27/12 20:23
7/25/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS-38573.970-5-768D
3/6/12 19:21
3/2/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS-2237.5233-1-148D22313-17-10-11-3-41
1/10/12 17:29
1/6/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS-7843.4633-2-444D48232434171213-31-2
11/21/11 17:21
11/18/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS-3338.0533-1-245D3323-132515-9-2-521390
4/4/11 20:25
4/1/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS.d-2835.0221-1-246D211432-7-9-5-311094-12
1/7/11 19:29
1/6/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS-6837.2825-2-918D4246734244-1-20-21-4221
1/7/10 19:06
1/6/10
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFust Matthew KCAOCFOS-5729.6019-2-1412D-46-17117854401-20-2624

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact